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The liver is the second largest organ in the body with a major
contribution to the regulation of systemic metabolism. This
places the liver at the centre of an extraordinary biomedical
interest due to the increased prevalence worldwide of liver-
associated diseases and due to the complex molecular back-
ground behind these conditions. Moreover, the liver plays a
key role in the control of whole-body energy through the
physiological regulation of different metabolisms including
that of sugars, lipids, and amino acids. The alteration of liver
metabolic homeostasis is critical for the development and
progression of different diseases including nonalcoholic fatty
liver disease (NAFLD), nonalcoholic steatohepatitis (NASH),
and hepatocellular carcinoma (HCC). These circumstances
generate a fertile ground for the definition of altered cellular
and molecular functions at the basis of these conditions. To
further increase our understanding of this complexity, this
special issue provides an overview of these processes with
potential advances in the development of diagnostic and
clinical applications.
Fatty liver is considered a consequence of a higher flux
of nonesterified fatty acids derived from adipose tissue
and/or an alteration in the hepatic energy metabolism that
facilitate intrahepatic fat accumulation. The study con-
ducted by G. Lattuada and collaborators focuses on this
clinical aspect. They evaluated the whole-body energy
metabolism and hepatic high-energy phosphates in nondi-
abetic individuals with fatty liver with respect to control
individuals matched for anthropometric features. The
study analysed the intrahepatic fat content by 1H-Magnetic
Resonance Spectroscopy, the relative content of hepatic high-
energy phosphates (phosphomonoesters, phosphodiesters,
inorganic phosphorus, and ATP) by 31P-Magnetic Reso-
nance Spectroscopy, and the whole-body resting energy
expenditure and substrate oxidation by indirect calorimetry.
The authors demonstrated that fasting whole-body energy
metabolism and the relative content of hepatic high-energy
phosphates in nondiabetic patients with fatty liver are not
different than in controls when the two groups of patients
are matched for anthropometric features.
F. Yang and collaborators investigated the role of
necroptosis during ischemia and reperfusion injury (IRI)
in fatty liver. They demonstrated that this cellular process
is activated during IRI and that targeting necroptosis can
have effects on IRI and ROS production with potential
clinical implications.
Experimental data support a role for oxidative stress in
the progression of NAFLD toward NASH. These works are
well reviewed byM. Masarone and colleagues, who presented
the main evidence on the strict pathophysiologic linkage
between oxidative stress and NAFLD. Oxidative stress may
also affect the synthesis and distribution of gangliosides as
reported by V. Šmíd and collaborators. As gangliosides are
involved in cell recognition, signalling, and membrane stabi-
lization, the alteration in their expression is often at the basis
of many pathological and physiological conditions including
cell death, proliferation, and differentiation. Using in vitro
and in vivo models, the authors evaluated the functional
consequences of Heme oxygenase 1 deficiency on ganglioside
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metabolism providing evidence of a tissue-specific increase
in the main gangliosides together with changes in the mRNA
expression of key enzymes of ganglioside synthesis.
O. Tirosh reviews key mechanisms responsible for the
occurrence of NAFLD in lean subjects with a healthy metab-
olism. In these subjects, the activation of several redox and
oxidant signalling pathways involving cholesterol plays a role
in fatty liver disease thus indicating that direct lipotoxic
effects, more than metabolic alterations, are crucial for the
disease progression. Main mechanisms responsible for the
cholesterol-induced NAFLD include impairment of the
mitochondrial and lysosomal function due to cholesterol
loading of the inner cell membrane and the activation of spe-
cific signalling and inflammatory pathways. This result has
clinical consequences for the development of personal drug
and dietary treatment strategies.
Chronic hepatic injury is often related to fibrosis, thus
leading to an excessive increase in extracellular matrix pro-
tein accumulation and fibrogenesis. Without proper clinical
management, liver damage may progress to cirrhosis and
ultimately to liver failure or cancer. M. Brancaccio and
collaborators put the spotlight on the effect of a marine com-
pound, isolated from sea urchin eggs, as a potential therapeu-
tic molecule for the treatment of liver fibrosis. In particular,
they report the effect of ovothiol A, π-methyl-5-thiohistidine,
on an in vivo murine model of liver fibrosis. Interestingly,
ovothiol A showed an antifibrotic effect associated with the
decrease of fibrogenic markers involved in liver fibrosis pro-
gression, such as the transforming growth factor-β (TGF-β),
the α-smooth muscle actin (α-SMA), and the tissue metallo-
proteinase inhibitor (TIMP-1). Similarly, in the work of Y.
Gao and colleagues, the protective effects of aqueous extracts
of Flos lonicerae Japonicae, a traditional Chinese medicine,
against hydroquinone-induced toxicity were demonstrated
using hepatic L02 cells. Aqueous extracts interfere with the
production of ROS mediated by hydroquinone, protecting
cells from DNA damage and apoptosis.
O. Vázquez-Martínez and collaborators used rat models
to evaluate the effect of portacaval anastomosis (PCA) on
liver metabolic parameters. Overall, data from their study
demonstrated significant liver metabolic and structural adap-
tations indicating a vascularization process and a reduction
of mitochondrial content as consequences of PCA.
Altered cellular metabolism is at the foundation of dif-
ferent liver diseases including HCC. Metabolic pathways
that support tumor pathophysiology were summarised by
S. De Matteis and collaborators in a comprehensive review
article. They discussed how metabolic pathways reprogram
liver metabolism to support a specific metabolic demand
and how this can be translated into a specific metabolic
signature clinically useful for the diagnosis and prognosis
of HCC.
Although detailed mechanisms remain to be fully eluci-
dated, several common observations emerge from this special
issue pointing to the role that oxidative stress and metabolic
pathways may play in liver-associated disorders. Indeed, clin-
ical and biological data clearly show significant differences
between normal and pathological conditions. As we are mov-
ing toward a systemic classification of human diseases, these
metabolic alterations have some practical perspectives in the
diagnostic and prognostic clinical field that should be taken
into account.
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